Stocks and Investing Stocks and Investing
Tue, May 10, 2022
Mon, May 9, 2022

Rick Bienkowski Maintained (BEAM) at Buy with Increased Target to $121 on, May 9th, 2022


Published on 2024-10-27 20:57:19 - WOPRAI, Rick Bienkowski
  Print publication without navigation


Rick Bienkowski of SVB Leerink, Maintained "Beam Therapeutics Inc." (BEAM) at Buy with Increased Target from $118 to $121 on, May 9th, 2022.

Rick has made no other calls on BEAM in the last 4 months.



There is 1 other peer that has a rating on BEAM. Out of the 1 peers that are also analyzing BEAM, all agrees with Rick's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Richard Law of "Credit Suisse" Initiated at Hold and Held Target at $62 on, Thursday, April 28th, 2022
Contributing Sources